Inventor · disambiguated record
Zachary C. Hartman
Also filed as: HARTMAN ZACHARY · HARTMAN ZACHARY C
9 granted patents·8 pending applications·13 citations·filing 2013–2023
81Inventor score
Top patents by PatentIndex Score
17 records- 0184US10487143B2Vaccines against HER3 antigens and methods of using the sameUNIV DUKE·Filed 2017·Granted Nov 26, 2019·3 cites·19 claims
- 0282US9956276B2Vaccines against antigens involved in therapy resistance and methods of using sameUNIV DUKE·Filed 2013·Granted May 1, 2018·8 cites·16 claims
- 0381US10842857B2Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the sameUNIV DUKE·Filed 2018·Granted Nov 24, 2020·1 cites·16 claims
- 0478US11235043B2Vaccines against antigens involved in therapy resistance and methods of using sameUNIV DUKE·Filed 2018·Granted Feb 1, 2022·1 cites·17 claims
- 0571US12083172B2Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the sameUNIV DUKE·Filed 2020·Granted Sep 10, 2024·0 cites·12 claims
- 0668US10842855B2Vaccines against an oncogenic isoform of ESR1 and methods of using the sameUNIV DUKE·Filed 2018·Granted Nov 24, 2020·0 cites·16 claims
- 0764US2024165228A1Targeted inhibition of dkk3 to sensitize tumors to immunotherapyUNIV DUKE·Filed 2023·Application pending·0 cites
- 0864US2021069309A1Vaccines against an oncogenic isoform of esr1 and methods of using the sameUNIV DUKE·Filed 2020·Application pending·0 cites
- 0959US2025205467A1Systems and methods for the treatment of cancer using ultrasoundUNIV DUKE·Filed 2023·Application pending·0 cites
- 1055US11224665B2Mitochondrial antiviral signaling (MAVS) protein compositions and methods of using the sameUNIV DUKE·Filed 2017·Granted Jan 18, 2022·0 cites·13 claims
- 1151US9932288B2Chemical compound for inhibition of SHP2 function and for use as an anti-cancer agentUNIV WEST VIRGINIA·Filed 2016·Granted Apr 3, 2018·0 cites·9 claims
- 1251US2017196953A1VACCINES AGAINST AN ONCOGENIC ISOFORM OF HER2 (ErbB2) AND METHODS OF USING THE SAMEUNIV DUKE·Filed 2015·Application pending·0 cites
- 1351US2021330773A1Vaccines against antigens involved in therapy resistance and methods of using sameUNIV DUKE·Filed 2021·Application pending·0 cites
- 1449US2022049015A1Compositions and methods for the treatment and/or prevention of her2+ cancersUNIV DUKE·Filed 2019·Application pending·0 cites
- 1546US11253580B2Cancer vaccines and methods of deliveryUNIV DUKE·Filed 2017·Granted Feb 22, 2022·0 cites·7 claims
- 1645US2017196952A1Vaccines against an oncogenic isoform of esr1 and methods of using the sameUNIV DUKE·Filed 2015·Application pending·0 cites
- 1744US2018282736A1Her3 vaccine vector compositions and methods of using the sameUNIV DUKE·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →